Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00528034 · ClinicalTrials.gov registry record · NA
Lymphoscintigraphy in Patients With Vaginal Cancer
A NA study of Vaginal Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT00528034: Completed NA study of Vaginal Cancer, sponsored by M.D. Anderson Cancer Center.
NCT00528034 is a NA study of Vaginal Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 14 participants, below the 602-participant average among 11 other Vaginal Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00528034, a NA study of Vaginal Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objectives: 1. Determine the feasibility of using pretreatment lymphoscintigraphy to identify the sentinel lymph node(s) in patients with vaginal cancer dispositioned to receive radiation therapy. 2. Determine the feasibility of using preoperative lymphoscintigraphy and intraoperative lymphatic mapping to identify the sentinel lymph node(s) in patients with vaginal cancer dispositioned to undergo surgery and bilateral lymph node dissection.
Conditions Studied
Interventions
- PROCEDURE Lymphoscintigraphy
Study Locations (1)
Texas
- U.T.M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2002-09 |
| Est. Completion | 2008-05 |
| Phase | NA |
What the finished NCT00528034 record still lists
NCT00528034 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 602-participant average among 11 other Vaginal Cancer trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Vaginal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Lymphoscintigraphy is the first listed.
NCT00528034 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00528034 about?
NCT00528034 is a clinical study titled "Lymphoscintigraphy in Patients With Vaginal Cancer". Primary Objectives: 1. Determine the feasibility of using pretreatment lymphoscintigraphy to identify the sentinel lymph node(s) in patients with vaginal cancer dispositioned to receive radiation therapy. 2. Determine the feasibility of using preoperative lymphoscintigraphy and intraoperative lymph...
What is the current status of trial NCT00528034?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2002-09. Estimated completion is 2008-05.
What conditions does trial NCT00528034 study?
This clinical trial studies the following conditions: Vaginal Cancer.
What interventions are being tested in trial NCT00528034?
The interventions under investigation include: Lymphoscintigraphy (PROCEDURE).
Who is sponsoring clinical trial NCT00528034?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00528034 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaginal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00528034's enrollment target sits among peer trials
14 12th of 11 the lowest of 11 other Vaginal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaginal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
Image-Guided Gynecologic Brachytherapy
RECRUITING · NA
-
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
COMPLETED · NA
-
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RECRUITING · Phase 2
-
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia